Sanofi teases appetite for larger deals, lifts 2026 growth targets under new CEO Garijo
Summary
Pharmaceutical company Sanofi has updated its financial goals for the year 2026 under the leadership of its new chief executive officer. Alongside these revised growth targets, the firm has indicated an interest in pursuing larger business transactions in the future.
Source: Read the full story at Stock Market News
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.